Loading company…
River BioMedics develops in vitro 3D heart models for drug discovery.
Founded in 2020 and based in Enschede, Netherlands, River BioMedics develops in vitro 3D heart models for drug discovery. CEO Nicky Cooper led the company as of 2023. In July 2023, it raised EUR 2 million in seed funding from Libertatis Ergo Holding B.V., with First Fund, KIKK Capital, and Oost NL participating. The funding was intended to support product development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in